Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2020 2
2021 2
2022 9
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms.
Geng X, Wang C, Gao X, Chowdhury P, Weiss J, Villegas JA, Saed B, Perera T, Hu Y, Reneau J, Sverdlov M, Wolfe A, Brown N, Harms P, Bailey NG, Inamdar K, Hristov AC, Tejasvi T, Montes J, Barrionuevo C, Taxa L, Casavilca S, de Pádua Covas Lage JLA, Culler HF, Pereira J, Runge JS, Qin T, Tsoi LC, Hong HS, Zhang L, Lyssiotis CA, Ohe R, Toubai T, Zevallos-Morales A, Murga-Zamalloa C, Wilcox RA. Geng X, et al. Among authors: culler hf. Blood Cancer J. 2022 Nov 4;12(11):149. doi: 10.1038/s41408-022-00745-y. Blood Cancer J. 2022. PMID: 36329027 Free PMC article.
Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): Retrospective data from a Latin American cohort.
de Pádua Covas Lage LA, Brito CV, Levy D, Culler HF, Freitas Couto SC, de Oliveira LBA, Nogueira Zerbini MC, Rocha V, Pereira J. de Pádua Covas Lage LA, et al. Among authors: culler hf. Leuk Res. 2022 Mar;114:106794. doi: 10.1016/j.leukres.2022.106794. Epub 2022 Feb 1. Leuk Res. 2022. PMID: 35131666
Up-front Therapy With CHOP Plus Etoposide in Brazilian nodal PTCL Patients: Increased Toxicity and No Survival Benefit Compared to CHOP Regimen-Results of a Real-Life Study From a Middle-Income Country.
Lage LAPC, Brito CV, Barreto GC, Culler HF, Reichert CO, Levy D, Costa RO, Zerbini MCN, Rocha V, Pereira J. Lage LAPC, et al. Among authors: culler hf. Clin Lymphoma Myeloma Leuk. 2022 Nov;22(11):812-824. doi: 10.1016/j.clml.2022.06.012. Epub 2022 Jun 29. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35869020
17 results